对帕金森病风险的短串重复的全基因组元分析,使用基因型归算
Olena Ohlei1, Kimberly Paul2, Susan Searles Nielsen3
1Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, 23562 Lübeck, Germany.
Brain communications
|June 12, 2024
概括
这项研究调查了短串重复 (STR) 作为帕金森病 (PD) 的风险因素. 虽然最初的发现没有被复制,但元分析显示了CCAR2和NCOR1附近的潜在STR关联,确定了新的暗示性PD风险位置.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 神经退行性疾病 神经退行性疾病
- 生物统计学 生物统计学
背景情况:
- 异常性帕金森病 (PD) 病因涉及复杂的遗传和环境相互作用.
- 之前的全基因组关联研究 (GWAS) 已经确定了PD的暗示性短串重复 (STR) 风险位置.
- STRs在PD病变发生中的作用需要进一步的验证和调查.
研究的目的:
- 在一个独立的队列中验证之前报告的基于STR的帕金森病风险位.
- 为了对帕金森病中STR进行大规模的分析,GWAS数据.
- 探索STR变异对死后脑组织基因表达的功能影响.
主要方法:
- 在一个大型PD病例控制数据集 (n=4757) 中对八个候选STR位点进行复制分析.
- 综合初始GWAS和复制数据 (总数n=43,844) 的元分析,以增加统计能力.
- 用人类死后大脑 (n=142) 的甲基化定量特征位点 (mQTL) 数据进行局部化分析,以评估功能影响.
主要成果:
- 在独立的数据集中,以前报告的八个STR中没有一个达到统计学意义.
- 更新后的元分析显示,STRs在CCAR2和NCOR1.1附近的支持很小.
- 鉴定了七个新的暗示性STR风险位点,其中一个值得注意的信号在MEIOSIN附近;局部化分析表明STR在CCAR2,NCOR1和LINC01012附近存在于PD风险和大脑DNA甲基化中.
结论:
- 在PD中最初的STR发现的复制没有成功,但元分析表明STR在CCAR2和NCOR1.1附近的潜在作用.
- 该研究确定了PD的新型暗示性STR风险位点,突出显示MEIOSIN是有前途的候选人.
- 功能性证据表明,特定的STR变异可能通过影响大脑中的DNA甲基化来影响PD风险,这需要进一步研究全基因组测序数据.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.0K
相关概念视频
01:11Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
01:05Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K